Thyroid dysfunction affects a large percentage of the global population and its incidence continues to increase.
According to Dr. Thierry Hertoghe, President of the International Hormone Society, 20-50% of the standard population is affected.
The British Medical Bulletin report on hypothyroidism in the UK reported 8% of all women and 3% of men had a hypothyroid condition. Age plays a further role for the female population over the age of 55, as the number of cases rises to 10%.
Hypothyroid data can be extrapolated to report that of the UK population over 2.3 million women and 640,000 men suffer from thyroid dysfunction. This is unsurprising when we consider the that many of the common symptoms reported in-clinic include the following, and in fact, be related to thyroid disorders i.e: lack of energy, weight gain, constipation, slow movements, thought and speech, pins and needles, breathlessness, dizziness, palpitations, loss of libido, dry/gritty eyes, hoarse voice, hair loss especially outer third of eyebrows, dry skin, muscle, and joint pain, Carpal Tunnel syndrome, and loss of appetite.
Establishing dysfunction for blood testing in the mainstream clinical realm is reserved for TSH and Free T4 only, yet a wealth of scientific data suggests that the choice of clinical ranges and markers used often miss the opportunity to diagnose thyroid dysfunction including autoimmune thyroid dysfunctions.
The thyroid story does not stop there, as autoimmune conditions are reported as rising in the populace and so is are thyroid autoimmune issues (Hashimoto’s and Graves). A study reported in the MBJ as far back as 2000, identified a doubling of reported autoimmune issues including thyroid in the young, and recently in 2018 10-12% of the populace was reported as suffering from autoimmune thyroid-related issues.
FDX considers that simply using TSH and Free T4 is not enough, and the identification of all of the available thyroid markers should be used.
FDX offers the most comprehensive blood chemistry testing in Europe with 2 markers dedicated to thyroid markers only and 2 other FDX panels that offer between 80 and over 100 biomarkers that includes all the available thyroid markers as well as the inclusion of many other biomarkers that enable thyroid assessment as well as a full assessment of the body’s systems, accessory system, etc..
FDX also offers an upgrade system allowing practitioners to assess thyroid only markers and then upgrade the test to one of the 2 larger comprehensive health reports and panels.
Our FDX panels have been created to look further than the norm (traditional blood analysis) to reveal more about your client’s health picture and to identify areas to focus on an effective treatment plan.
FunctionalDX uses the world’s most advanced blood interpretation technology considers 13 body systems, 7 accessory systems, 7 macronutrient systems, 14 micronutrient deficiencies, and over 40 possible clinical dysfunctions.